These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20587623)

  • 1. Nutritional status affects fluvastatin-induced hepatotoxicity and myopathy in rats.
    Sugatani J; Sadamitsu S; Kurosawa M; Ikushiro S; Sakaki T; Ikari A; Miwa M
    Drug Metab Dispos; 2010 Oct; 38(10):1655-64. PubMed ID: 20587623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet.
    Osabe M; Sugatani J; Fukuyama T; Ikushiro S; Ikari A; Miwa M
    Drug Metab Dispos; 2008 Feb; 36(2):294-302. PubMed ID: 17967931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.
    Sugatani J; Wada T; Osabe M; Yamakawa K; Yoshinari K; Miwa M
    Drug Metab Dispos; 2006 Oct; 34(10):1677-87. PubMed ID: 16815962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deteriorating effect of fluvastatin on the cholestatic liver injury induced by bile duct ligation in rats.
    Lotková H; Staňková P; Roušar T; Kučera O; Kohoutek L; Mičuda S; Brčáková E; Kolouchová G; Cervinková Z
    Gen Physiol Biophys; 2011 Mar; 30(1):66-74. PubMed ID: 21460414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic drug interaction between fexofenadine and fluvastatin mediated by organic anion-transporting polypeptides in rats.
    Qiang F; Lee BJ; Lee W; Han HK
    Eur J Pharm Sci; 2009 Jun; 37(3-4):413-7. PubMed ID: 19428223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
    Barilla D; Prasad P; Hubert M; Gumbhir-Shah K
    Biopharm Drug Dispos; 2004 Mar; 25(2):51-9. PubMed ID: 14872552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery.
    Voûte MT; Winkel TA; Poldermans D
    Expert Opin Drug Saf; 2010 Sep; 9(5):793-800. PubMed ID: 20557267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin.
    Ayalasomayajula SP; Vaidyanathan S; Kemp C; Prasad P; Balch A; Dole WP
    J Clin Pharmacol; 2007 May; 47(5):613-9. PubMed ID: 17442686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
    Niemi M; Pasanen MK; Neuvonen PJ
    Clin Pharmacol Ther; 2006 Oct; 80(4):356-66. PubMed ID: 17015053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated clinical safety experience with fluvastatin.
    Jokubaitis LA
    Am J Cardiol; 1994 May; 73(14):18D-24D. PubMed ID: 8198019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Induced Acute Liver Injury Within 12 Hours After Fluvastatin Therapy.
    Li L; Ma Y; Geng XB; Song YX; Tan Z; Shang XM; Zhao GY; Zhao BQ; Tian MR
    Am J Ther; 2016; 23(1):e318-20. PubMed ID: 24451297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential changes in the pharmacokinetics of statins in collagen-induced arthritis rats.
    Lin CH; Hsu KW; Chen CH; Uang YS; Lin CJ
    Biochem Pharmacol; 2017 Oct; 142():216-228. PubMed ID: 28636885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary inulin, statin, and their co-treatment on hyperlipidemia, hepatic steatosis and changes in drug-metabolizing enzymes in rats fed a high-fat and high-sucrose diet.
    Sugatani J; Sadamitsu S; Wada T; Yamazaki Y; Ikari A; Miwa M
    Nutr Metab (Lond); 2012 Mar; 9(1):23. PubMed ID: 22452877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres.
    Sakamoto K; Mikami H; Kimura J
    Br J Pharmacol; 2008 Aug; 154(7):1482-90. PubMed ID: 18500364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fluvastatin in subjects with renal impairment and nephrotic syndrome.
    Appel-Dingemanse S; Smith T; Merz M
    J Clin Pharmacol; 2002 Mar; 42(3):312-8. PubMed ID: 11865968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvastatin, rhabdomyolysis, and myotoxicity.
    Murinson BB; Maragakis NJ; Jacobson TA
    Mayo Clin Proc; 2008 Nov; 83(11):1296; author reply 1297. PubMed ID: 18990330
    [No Abstract]   [Full Text] [Related]  

  • 18. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy.
    Eng H; Scialis RJ; Rotter CJ; Lin J; Lazzaro S; Varma MV; Di L; Feng B; West M; Kalgutkar AS
    Drug Metab Dispos; 2016 May; 44(5):692-9. PubMed ID: 26888941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The difference in pharmacokinetics and pharmacodynamics between extended-release fluvastatin and immediate-release fluvastatin in healthy Chinese subjects.
    Xu HR; Chen WL; Chu NN; Li XN; Zhu JR
    J Biomed Biotechnol; 2012; 2012():386230. PubMed ID: 22811596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.